CAN
KYNB

Cetera Advisor Networks’s Kyntra Bio KYNB Stock Holding History

Cetera Advisor Networks’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$24.6K Buy
+418
New +$18K ﹤0.01% 2775

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Cetera Advisor Networks's KYNB Position: Q1 2024 in Review

Cetera Advisor Networks opened a new position in Kyntra Bio (KYNB) in Q1 2024: 418 shares worth $24.6K. The stake represents ﹤0.01% of the portfolio and ranks #2775 among its holdings.

112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Cetera Advisor Networks held 418 shares of Kyntra Bio worth $24.6K as of Q1 2024.
  • Kyntra Bio was a new Cetera Advisor Networks position in Q1 2024.
  • Kyntra Bio made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2775 holding.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.